Mechanisms of cisplatin-induced ototoxicity and prevention

@article{Rybak2007MechanismsOC,
  title={Mechanisms of cisplatin-induced ototoxicity and prevention},
  author={Leonard P Rybak and Craig A. Whitworth and Debashree Mukherjea and Vickram Ramkumar},
  journal={Hearing Research},
  year={2007},
  volume={226},
  pages={157-167}
}
View on Elsevier
doi.org
453 Citations
Highly Influential Citations
23
Background Citations
190
Methods Citations
1
Results Citations
6

453 Citations

Citation Type

Citation Type

Cisplatin-induced ototoxicity: updates on molecular mechanisms and otoprotective strategies.
  • Qing Tang, Xianren Wang, Z. Zou
  • Biology
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
  • 2021
Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity
TLDR
There is an urgent need to discover safe and effective protective agents that do not interfere with the efficacy of cisplatin against tumors yet preserve hearing, and a number of potential therapeutic targets that can be addressed to provide hearing protection.
Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies
TLDR
Clinical and experimental studies of cisplatin ototoxicity are summarized, and understanding its toxicity mechanisms, clinical repercussions and prevention strategies are focused on.
Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models
TLDR
The aim of the present review is to analyze the role of ROS in the mechanisms causing cisplatin-mediated apoptosis in the inner ear and the contribution of the different pathways involved, emphasizing the main strategies to blockade events leading to apoptosis of cochlear cells.
Cisplatin-induced ototoxicity: Transporters playing a role in cisplatin toxicity
Mechanisms of cisplatin ototoxicity and progress in otoprotection
  • L. Rybak
  • Biology
    Current opinion in otolaryngology & head and neck surgery
  • 2007
TLDR
This review presents exciting new data published in the past year that help to elucidate the mechanisms of cisplatin ototoxicity and could lead to important clinical trials to determine whether the findings in experimental animals can translate into effective treatments to prevent cisPlatin ottoxicity.
In vitro protective effects of Ginkgo biloba against cisplatin toxicity in mouse cell line OCk3
TLDR
The hypothesis that pre-treatment with Ginkgo biloba extract is able to protect OCk3 against cisplatin induced toxicity in a mouse inner ear cell line (OCk3) is supported.
Cisplatin ototoxicity and protection: clinical and experimental studies.
TLDR
Recent important clinical and experimental investigations of cisplatin ototoxicity are summarized and the utility of protective agents employed in patients and in experimental animals is discussed.
Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity
TLDR
Alpha-lipoic acid contributes to protecting mitochondrial function by preventing ROS accumulation and inhibiting apoptotic cell death and post-treatment with ALA consistently showed an almost equal restorative effect to pretreatment, in vitro and in vivo, supporting the possible use of ALA as a therapeutic agent for cisplatin-induced ototoxicity.
A Review of Cisplatin-Associated Ototoxicity.
TLDR
The importance of a team-based approach to complement an audiological monitoring program in reducing any further loss in the quality of life of affected patients is highlighted, as there is currently no otoprotective agent routinely recommended for the prevention of cisplatin-associated ototoxicity.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 83 REFERENCES
Ototoxicity: therapeutic opportunities.
Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS.
Mechanism of cisplatin ototoxicity: antioxidant system.
TLDR
Cisplatin ototoxicity was evidenced as elevated hearing thresholds and prolonged wave I latencies in response to various stimuli on ABRs, and superoxide dismutase, catalase activities and malondialdehyde levels were significantly increased in the cochleae of cisplatin injected rats.
Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen
Protection against cisplatin ototoxicity by adenosine agonists.
Effect of protective agents against cisplatin ototoxicity.
TLDR
The results suggest the possibility that the clinical use of protective agents could effectively reduce or prevent damage to the inner ear of patients receiving cisplatin chemotherapy, provided that the antitumor effect is not altered.
Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model
Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
  • L. Muldoon, M. Pagel, E. Neuwelt
  • Biology, Medicine
    Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2000
TLDR
Delayed administration of sodium thiosulfate (STS) may provide a mechanism to reduce the ototoxicity caused by administration of carboplatin or cisplatin for both central nervous system and systemic cancer chemotherapy.
SEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINE
TLDR
A case of severe toxicity with cisplatin is reported in a girl with epithelial cell carcinoma of the ovary despite the use of amifostine, a broad-spectrum cytoprotector of normal tissues, according to the authors.
Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig
...
1
2
3
4
5
...